Dr. Katharine Schulz-Costello, DO

Dr. Schulz-Costello practices at City of Hope Comprehensive Cancer Center - Duarte in Duarte, California.

Dr. Schulz-Costello's NPI, 1154684538, was assigned on June 20, 2012. Dr. Schulz-Costello graduated from WesternU College of Osteopathic Medicine of the Pacific in 2012. Dr. Schulz-Costello's California license number on file is 20A13042.

Dr. Schulz-Costello's primary practice is City of Hope Comprehensive Cancer Center - Duarte, at 1500 Duarte Rd, Duarte, CA 91010 in Los Angeles County. The practice phone is (800) 826-4673.

Dr. Schulz-Costello's primary practice is City of Hope Comprehensive Cancer Center - Duarte in Duarte, California. The medical group on file is City of Hope. Dmand AI also links Dr. Schulz-Costello to 1 more group practice or clinic and 1 other site, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Schulz-Costello practices, 2 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Schulz-Costello's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Schulz-Costello is board certified in surgery by the AOA Board of Surgery. Dmand AI has Dr. Schulz-Costello's licenses on file in 2 states: California and Maryland.

Dmand AI lists breast reconstruction and mastectomy among the conditions Dr. Schulz-Costello treats.

CMS data shows 500 Medicare services from Dr. Schulz-Costello across 13 procedure codes in 2024, for 203 Medicare patients. Medicare paid $71,735 for them.

CMS counts 203 Medicare patients who saw Dr. Schulz-Costello in 2024. The largest group is 65 to 74, with 96 patients. 75% of them have cancer, and 75% have high cholesterol. 31% are also on Medicaid. Their average risk score is 1.44, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Schulz-Costello's median patient age at 62, with 98% women.

In 2024, Dr. Schulz-Costello wrote 61 Medicare Part D claims for 42 patients. 98% of them were for generic drugs. CMS names the drug for 25 of them, across 1 drug with 11 or more claims each, at $79 in total drug cost. In 2023, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Schulz-Costello for performance year 2024, reported as part of a group. Dr. Schulz-Costello accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Schulz-Costello as offering telehealth. CMS counts 33 procedures of mastectomy by Dr. Schulz-Costello, more than 88% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 2 papers to Dr. Schulz-Costello, published from 2024 to 2025. The most frequent topics are Chemotherapy, Adjuvant and Neoadjuvant Therapy. Dr. Schulz-Costello's most frequent co-authors are Veronica Christine Jones, MD, Fang Fan, MD, PhD and Min Han, MD, PhD.

CMS Open Payments shows 18 general payments to Dr. Schulz-Costello from 12 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 72% of the total. Intuitive Surgical, Inc. paid the most, $527.

Dr. Schulz-Costello graduated from WesternU College of Osteopathic Medicine of the Pacific in 2012. Dr. Schulz-Costello is a member of AOA.

Dr. Schulz-Costello is in network with 15 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.